Concepts (216)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macaca mulatta | 22 | 2026 | 139 | 3.760 |
Why?
|
| Dengue | 14 | 2023 | 107 | 3.150 |
Why?
|
| Dengue Virus | 14 | 2023 | 96 | 2.290 |
Why?
|
| Antibodies, Viral | 15 | 2024 | 306 | 1.890 |
Why?
|
| Antibodies, Neutralizing | 11 | 2024 | 127 | 1.660 |
Why?
|
| Immunity, Humoral | 2 | 2021 | 29 | 1.340 |
Why?
|
| Antibody-Dependent Enhancement | 2 | 2017 | 3 | 1.080 |
Why?
|
| Genetic Variation | 3 | 2026 | 430 | 0.980 |
Why?
|
| Major Histocompatibility Complex | 1 | 2026 | 29 | 0.950 |
Why?
|
| Immunity, Cellular | 2 | 2020 | 74 | 0.790 |
Why?
|
| Immunoglobulin G | 1 | 2024 | 259 | 0.760 |
Why?
|
| Immunity, Innate | 4 | 2020 | 171 | 0.750 |
Why?
|
| Interferons | 2 | 2013 | 40 | 0.670 |
Why?
|
| T-Lymphocytes | 3 | 2020 | 386 | 0.650 |
Why?
|
| Genes, MHC Class I | 1 | 2018 | 15 | 0.570 |
Why?
|
| Genes, MHC Class II | 1 | 2018 | 21 | 0.570 |
Why?
|
| Specific Pathogen-Free Organisms | 4 | 2026 | 24 | 0.560 |
Why?
|
| Flaviviridae Infections | 1 | 2017 | 1 | 0.550 |
Why?
|
| Gene Frequency | 1 | 2018 | 206 | 0.550 |
Why?
|
| Dengue Vaccines | 4 | 2021 | 16 | 0.550 |
Why?
|
| Animals | 25 | 2026 | 16992 | 0.540 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 209 | 0.540 |
Why?
|
| Flavivirus | 1 | 2017 | 16 | 0.530 |
Why?
|
| Vaccination | 5 | 2026 | 355 | 0.530 |
Why?
|
| Cytokines | 6 | 2019 | 678 | 0.520 |
Why?
|
| Puerto Rico | 6 | 2021 | 1413 | 0.510 |
Why?
|
| Viral Envelope Proteins | 7 | 2023 | 91 | 0.510 |
Why?
|
| Microsatellite Repeats | 3 | 2026 | 61 | 0.490 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 5 | 2019 | 57 | 0.450 |
Why?
|
| Serine Endopeptidases | 2 | 2019 | 48 | 0.440 |
Why?
|
| Viral Nonstructural Proteins | 2 | 2019 | 53 | 0.430 |
Why?
|
| Immune Evasion | 1 | 2013 | 17 | 0.410 |
Why?
|
| Male | 18 | 2026 | 23409 | 0.410 |
Why?
|
| I-kappa B Kinase | 1 | 2013 | 51 | 0.390 |
Why?
|
| Simian immunodeficiency virus | 5 | 2019 | 60 | 0.390 |
Why?
|
| Toll-Like Receptor 8 | 1 | 2011 | 5 | 0.350 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2011 | 4 | 0.350 |
Why?
|
| Cross Reactions | 4 | 2021 | 87 | 0.350 |
Why?
|
| Breeding | 2 | 2016 | 28 | 0.350 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2011 | 12 | 0.350 |
Why?
|
| Meningoencephalitis | 1 | 2009 | 14 | 0.310 |
Why?
|
| Mycobacterium Infections | 1 | 2009 | 16 | 0.310 |
Why?
|
| Humans | 24 | 2026 | 43102 | 0.300 |
Why?
|
| Herpesvirus 1, Cercopithecine | 2 | 2006 | 3 | 0.290 |
Why?
|
| Virus Replication | 1 | 2011 | 318 | 0.290 |
Why?
|
| Female | 13 | 2026 | 24698 | 0.250 |
Why?
|
| Cervix Uteri | 2 | 2019 | 48 | 0.250 |
Why?
|
| Vagina | 2 | 2019 | 89 | 0.250 |
Why?
|
| Immunity | 2 | 2019 | 61 | 0.250 |
Why?
|
| Dendritic Cells | 2 | 2020 | 132 | 0.250 |
Why?
|
| Transcriptional Activation | 1 | 2007 | 173 | 0.250 |
Why?
|
| Time Factors | 3 | 2020 | 1857 | 0.240 |
Why?
|
| Genetics, Population | 2 | 2017 | 121 | 0.240 |
Why?
|
| Mouth | 1 | 2026 | 54 | 0.240 |
Why?
|
| Monkey Diseases | 1 | 2005 | 7 | 0.230 |
Why?
|
| Herpesviridae Infections | 1 | 2005 | 17 | 0.230 |
Why?
|
| Social Alienation | 1 | 2023 | 4 | 0.210 |
Why?
|
| HLA-DR Antigens | 1 | 2023 | 23 | 0.210 |
Why?
|
| Neutralization Tests | 2 | 2021 | 57 | 0.200 |
Why?
|
| Viremia | 3 | 2019 | 44 | 0.200 |
Why?
|
| AIDS Vaccines | 3 | 2007 | 26 | 0.180 |
Why?
|
| Caribbean Region | 2 | 2016 | 79 | 0.180 |
Why?
|
| Cross Protection | 1 | 2021 | 5 | 0.180 |
Why?
|
| RNA, Viral | 3 | 2001 | 321 | 0.170 |
Why?
|
| Mucous Membrane | 2 | 2019 | 34 | 0.170 |
Why?
|
| K562 Cells | 2 | 2017 | 32 | 0.160 |
Why?
|
| Immunologic Factors | 1 | 2020 | 51 | 0.160 |
Why?
|
| Semen | 1 | 2019 | 57 | 0.150 |
Why?
|
| RNA, Messenger | 1 | 2024 | 1271 | 0.150 |
Why?
|
| Animals, Laboratory | 1 | 2018 | 3 | 0.140 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 1067 | 0.140 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2019 | 279 | 0.140 |
Why?
|
| Primate Diseases | 1 | 2017 | 4 | 0.140 |
Why?
|
| Mutation | 2 | 2021 | 1177 | 0.140 |
Why?
|
| Protein Binding | 1 | 2021 | 1082 | 0.140 |
Why?
|
| Vaccines, DNA | 3 | 2007 | 24 | 0.140 |
Why?
|
| Haplotypes | 1 | 2018 | 197 | 0.140 |
Why?
|
| Animal Population Groups | 1 | 2017 | 1 | 0.130 |
Why?
|
| Immune Sera | 1 | 2017 | 56 | 0.130 |
Why?
|
| Animals, Wild | 1 | 2017 | 24 | 0.130 |
Why?
|
| Pedigree | 1 | 2017 | 94 | 0.130 |
Why?
|
| Alleles | 1 | 2018 | 352 | 0.130 |
Why?
|
| Cell Line | 2 | 2019 | 1410 | 0.130 |
Why?
|
| Models, Animal | 1 | 2017 | 151 | 0.130 |
Why?
|
| Genetic Drift | 1 | 2016 | 6 | 0.120 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 2015 | 13 | 0.120 |
Why?
|
| Adult | 5 | 2026 | 13872 | 0.110 |
Why?
|
| Lymph Nodes | 2 | 2007 | 74 | 0.100 |
Why?
|
| Serologic Tests | 2 | 2022 | 45 | 0.100 |
Why?
|
| Endometrium | 1 | 2014 | 59 | 0.100 |
Why?
|
| Protein Interaction Mapping | 1 | 2013 | 65 | 0.100 |
Why?
|
| Encephalitis Virus, Venezuelan Equine | 1 | 2013 | 11 | 0.100 |
Why?
|
| Aged | 2 | 2026 | 8214 | 0.100 |
Why?
|
| Middle Aged | 4 | 2026 | 12222 | 0.090 |
Why?
|
| Flow Cytometry | 2 | 2011 | 411 | 0.090 |
Why?
|
| Inflammation | 2 | 2023 | 758 | 0.090 |
Why?
|
| Serotyping | 2 | 2014 | 37 | 0.090 |
Why?
|
| Leukocytes, Mononuclear | 2 | 2011 | 247 | 0.090 |
Why?
|
| Longitudinal Studies | 2 | 2026 | 1063 | 0.090 |
Why?
|
| HIV-1 | 3 | 2007 | 755 | 0.090 |
Why?
|
| Cells, Cultured | 2 | 2013 | 1621 | 0.090 |
Why?
|
| Drug Carriers | 1 | 2013 | 174 | 0.090 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 15 | 0.080 |
Why?
|
| Interleukin-18 | 1 | 2010 | 17 | 0.080 |
Why?
|
| Interleukin-12 | 1 | 2010 | 46 | 0.080 |
Why?
|
| Morphine Dependence | 1 | 2010 | 23 | 0.080 |
Why?
|
| Amino Acid Sequence | 5 | 2014 | 1180 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2007 | 458 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2009 | 48 | 0.080 |
Why?
|
| Granuloma | 1 | 2009 | 24 | 0.080 |
Why?
|
| Genetics | 1 | 2007 | 10 | 0.070 |
Why?
|
| Epidemiology | 1 | 2007 | 9 | 0.070 |
Why?
|
| Molecular Sequence Data | 4 | 2014 | 1542 | 0.070 |
Why?
|
| Vaccines, Attenuated | 2 | 2019 | 75 | 0.070 |
Why?
|
| Digestive System | 1 | 2007 | 21 | 0.070 |
Why?
|
| Simian T-lymphotropic virus 1 | 1 | 2006 | 6 | 0.060 |
Why?
|
| Seroepidemiologic Studies | 1 | 2006 | 74 | 0.060 |
Why?
|
| Marburgvirus | 1 | 2006 | 8 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2007 | 195 | 0.060 |
Why?
|
| Vaccinia virus | 1 | 2006 | 13 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2023 | 184 | 0.060 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2007 | 310 | 0.060 |
Why?
|
| Ebolavirus | 1 | 2006 | 49 | 0.060 |
Why?
|
| Glycoproteins | 1 | 2006 | 125 | 0.060 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2026 | 203 | 0.060 |
Why?
|
| Animal Husbandry | 1 | 2005 | 21 | 0.060 |
Why?
|
| Sex Characteristics | 1 | 2006 | 258 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2005 | 120 | 0.050 |
Why?
|
| Proteins | 1 | 2007 | 382 | 0.050 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 592 | 0.050 |
Why?
|
| Cuba | 2 | 2001 | 33 | 0.050 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2007 | 652 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 611 | 0.050 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 704 | 0.050 |
Why?
|
| Bacteria | 1 | 2026 | 293 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2021 | 19 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2007 | 1070 | 0.040 |
Why?
|
| Algorithms | 1 | 2005 | 509 | 0.040 |
Why?
|
| Child | 3 | 2015 | 3443 | 0.040 |
Why?
|
| Antigens, Viral | 1 | 2021 | 48 | 0.040 |
Why?
|
| Hepatitis A Virus, Human | 1 | 2001 | 1 | 0.040 |
Why?
|
| Hepatitis A | 1 | 2001 | 11 | 0.040 |
Why?
|
| Aging | 1 | 2006 | 783 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2019 | 1596 | 0.040 |
Why?
|
| Mice | 3 | 2021 | 6644 | 0.040 |
Why?
|
| Base Sequence | 2 | 1999 | 983 | 0.040 |
Why?
|
| Consensus Sequence | 1 | 1999 | 21 | 0.040 |
Why?
|
| Paraffin Embedding | 1 | 1999 | 15 | 0.040 |
Why?
|
| Autopsy | 1 | 1999 | 48 | 0.040 |
Why?
|
| Nucleoside-Triphosphatase | 1 | 2019 | 13 | 0.040 |
Why?
|
| RNA Helicases | 1 | 2019 | 19 | 0.040 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2019 | 25 | 0.040 |
Why?
|
| Receptors, CCR5 | 1 | 2019 | 64 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 665 | 0.040 |
Why?
|
| DNA Primers | 1 | 1999 | 294 | 0.040 |
Why?
|
| Diagnosis, Differential | 1 | 1999 | 238 | 0.040 |
Why?
|
| Spleen | 1 | 1999 | 204 | 0.040 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 78 | 0.040 |
Why?
|
| Genotype | 1 | 2021 | 800 | 0.040 |
Why?
|
| HIV Infections | 2 | 2019 | 2586 | 0.040 |
Why?
|
| Virulence | 1 | 2019 | 246 | 0.040 |
Why?
|
| Disease Outbreaks | 1 | 1999 | 175 | 0.040 |
Why?
|
| Liver | 1 | 1999 | 511 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2021 | 1869 | 0.030 |
Why?
|
| Injections, Subcutaneous | 1 | 2015 | 36 | 0.030 |
Why?
|
| Thailand | 1 | 2015 | 51 | 0.030 |
Why?
|
| Singapore | 1 | 2015 | 33 | 0.030 |
Why?
|
| Colombia | 1 | 2015 | 31 | 0.030 |
Why?
|
| Child, Preschool | 2 | 2015 | 1546 | 0.030 |
Why?
|
| Phylogeny | 1 | 1999 | 769 | 0.030 |
Why?
|
| Safety | 1 | 2015 | 54 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2015 | 317 | 0.030 |
Why?
|
| Plasma | 1 | 2014 | 38 | 0.030 |
Why?
|
| United States | 1 | 2005 | 5205 | 0.030 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2014 | 201 | 0.030 |
Why?
|
| Species Specificity | 1 | 2014 | 286 | 0.020 |
Why?
|
| Macaca | 1 | 2013 | 36 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2014 | 115 | 0.020 |
Why?
|
| Vaccines, Synthetic | 1 | 2013 | 80 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 1999 | 2544 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 423 | 0.020 |
Why?
|
| Viral Load | 1 | 2014 | 348 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2013 | 165 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2014 | 518 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2014 | 506 | 0.020 |
Why?
|
| Infant | 1 | 2015 | 1175 | 0.020 |
Why?
|
| Genes | 1 | 2007 | 56 | 0.020 |
Why?
|
| Fusion Proteins, gag-pol | 1 | 2007 | 2 | 0.020 |
Why?
|
| HIV Core Protein p24 | 1 | 2007 | 12 | 0.020 |
Why?
|
| Chromosomes, Human | 1 | 2007 | 37 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 2007 | 19 | 0.020 |
Why?
|
| Rectum | 1 | 2007 | 27 | 0.020 |
Why?
|
| Molecular Biology | 1 | 2007 | 47 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2007 | 199 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2007 | 109 | 0.020 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2006 | 25 | 0.020 |
Why?
|
| Lymphocytes | 1 | 2007 | 124 | 0.020 |
Why?
|
| Administration, Rectal | 1 | 2006 | 18 | 0.020 |
Why?
|
| Africa, Western | 1 | 2005 | 19 | 0.010 |
Why?
|
| Gene Products, gag | 1 | 2005 | 12 | 0.010 |
Why?
|
| Gene Products, env | 1 | 2005 | 23 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2005 | 76 | 0.010 |
Why?
|
| Monocytes | 1 | 2007 | 277 | 0.010 |
Why?
|
| Epitopes | 1 | 2005 | 157 | 0.010 |
Why?
|
| Young Adult | 1 | 2015 | 5080 | 0.010 |
Why?
|
| Plasmids | 1 | 2005 | 244 | 0.010 |
Why?
|
| Adolescent | 1 | 2015 | 6081 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 532 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 372 | 0.010 |
Why?
|
| Molecular Epidemiology | 1 | 2001 | 59 | 0.010 |
Why?
|
| Sequence Analysis, Protein | 1 | 2001 | 52 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 2001 | 272 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 314 | 0.010 |
Why?
|
| Genome, Viral | 1 | 2001 | 119 | 0.010 |
Why?
|
| Apoptosis | 1 | 2006 | 1568 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 1996 | 455 | 0.010 |
Why?
|